PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies
Clinical trial NCT03030001 · UNKNOWN
Trial details
- NCT number
- NCT03030001
- Sponsor
- Ningbo Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-15
- Primary completion
- 2018-12-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.